Dr. Mari Aparici is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94305Phone+1 650-723-2325
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Nuclear Medicine, 2003 - 2005
- Universidad de Valencia Faculty of MedicineClass of 1992
Certifications & Licensure
- CA State Medical License 2005 - 2025
- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- 68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO) Start of enrollment: 2019 Jan 15
Roles: Contact, Sponsor-Investigator, Principal Investigator
- A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer Start of enrollment: 2021 Sep 14
Roles: Contact
- Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE Start of enrollment: 2021 Dec 21
Roles: Contact
Publications & Presentations
PubMed
- 2 citationsSame-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [Lu]Lu-PSMA-617 in metastatic castration-resistant p...Hong Song, Maria Isabel Leonio, Valentina Ferri, Heying Duan, Carina Mari Aparici
European Journal of Nuclear Medicine and Molecular Imaging. 2024-07-01 - ACR-ACNM-ARS-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radiopharmaceuticals.Paul E Wallner, Don C Yoo, Jeremie Calais, Freddy E Escorcia, Carina Mari Aparici
American Journal of Clinical Oncology. 2024-04-01 - Definitive Treatment of Brain Metastases From a Neuroendocrine Tumor With Peptide Receptor Radionuclide Therapy With 177Lutetium DOTATATE: A Case Report.Vivian Zhang, Kekoa Taparra, George Fisher, Carina Aparici, Scott G Soltys
Cureus. 2023-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: